Journal of Antimicrobial Chemotherapy (2001) 48, 605-608
© 2001 The British Society for Antimicrobial Chemotherapy
A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum
Bristol Centre for Antimicrobial Research and Evaluation, Department of Microbiology, Southmead Hospital, Bristol BS10 5NB, UK
A rapid high-performance liquid chromatography (HPLC) assay for the detection of linezolid in human serum was developed. The method used a Hypersil 5ODS stationary phase. The mobile phase was 1% ortho-phosphoric acid, 30% methanol, 2 g/L heptane sulphonic acid, pH 5. UV absorbance detection was used (Ïmax 254 nm). Samples were prepared by mixing with acetonitrile and an injection volume of 20 ÌL was used. The inter- and intra-day assay reproducibility were assessed. Assay linearity, specificity and accuracy were investigated. The detection limit and recovery of linezolid from serum were determined. In addition, the stability of linezolid, stored under a variety of conditions, was assessed. The retention time of linezolid was c. 6.5 min. The intra- and inter-day reproducibility was good and the assay was linear across the therapeutic range. Serum recovery was c. 100% at all concentrations tested. The detection limit was 0.1 mg/L and the assay was accurate. The assay was specific as there was no significant interference with the linezolid peak. Linezolid was demonstrated to be stable. This rapid assay is ideal for busy clinical laboratories with basic HPLC equipment.
* Corresponding author. Tel: +44-117-959-5654; Fax: +44-117-959-3217; E-mail: tobin_c{at}southmead.swest.nhs.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. Lovering, R. Le Floch, L. Hovsepian, J. Stephanazzi, P. Bret, G. Birraux, and C. Vinsonneau Pharmacokinetic evaluation of linezolid in patients with major thermal injuries J. Antimicrob. Chemother., March 1, 2009; 63(3): 553 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Myrianthefs, S. L. Markantonis, K. Vlachos, M. Anagnostaki, E. Boutzouka, D. Panidis, and G. Baltopoulos Serum and Cerebrospinal Fluid Concentrations of Linezolid in Neurosurgical Patients Antimicrob. Agents Chemother., December 1, 2006; 50(12): 3971 - 3976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grunder, Y. Zysset-Aschmann, F. Vollenweider, T. Maier, S. Krahenbuhl, and J. Drewe Lack of Pharmacokinetic Interaction between Linezolid and Antacid in Healthy Volunteers Antimicrob. Agents Chemother., January 1, 2006; 50(1): 68 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Swoboda, S. Fritz, M. E. Martignoni, R. A. Feldhues, T. Hoppe-Tichy, M. W. Buchler, and H. K. Geiss Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report J. Antimicrob. Chemother., October 1, 2005; 56(4): 787 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Beringer, M. Nguyen, N. Hoem, S. Louie, M. Gill, M. Gurevitch, and A. Wong-Beringer Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3676 - 3681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Whitehouse, J. A. Cepeda, R. Shulman, L. Aarons, R. Nalda-Molina, C. Tobin, A. MacGowan, S. Shaw, C. Kibbler, M. Singer, et al. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill J. Antimicrob. Chemother., March 1, 2005; 55(3): 333 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Krueger, B. Kottler, B. E. Will, A. Heininger, H. Guggenberger, and K. E. Unertl Treatment of Meningitis Due to Methicillin-Resistant Staphylococcus epidermidis with Linezolid J. Clin. Microbiol., February 1, 2004; 42(2): 929 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saralaya, D. G. Peckham, B. Hulme, C. M. Tobin, M. Denton, S. Conway, and C. Etherington Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis J. Antimicrob. Chemother., February 1, 2004; 53(2): 325 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kutscha-Lissberg, U. Hebler, G. Muhr, and M. Koller Linezolid Penetration into Bone and Joint Tissues Infected with Methicillin-Resistant Staphylococci Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3964 - 3966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Honeybourne, C. Tobin, G. Jevons, J. Andrews, and R. Wise Intrapulmonary penetration of linezolid J. Antimicrob. Chemother., June 1, 2003; 51(6): 1431 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Tobin, J. Sunderland, A. M. Lovering, and A. P. MacGowan A high performance liquid chromatography (HPLC) assay for linezolid in continuous ambulatory peritoneal dialysis fluid (CAPDF) J. Antimicrob. Chemother., April 1, 2003; 51(4): 1041 - 1042. [Full Text] [PDF]
|
|
|
|
|
|
B. Rana, I. Butcher, P. Grigoris, C. Murnaghan, R. A. Seaton, and C. M. Tobin Linezolid penetration into osteo-articular tissues J. Antimicrob. Chemother., November 1, 2002; 50(5): 747 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Lovering, J. Zhang, G. C. Bannister, B. J. A. Lankester, J. H. M. Brown, G. Narendra, and A. P. MacGowan Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement J. Antimicrob. Chemother., July 1, 2002; 50(1): 73 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Rao, A. Steger, and C. M. Tobin Linezolid levels in pancreatic secretions J. Antimicrob. Chemother., December 1, 2001; 48(6): 931 - 932. [Full Text] [PDF]
|
|